|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
FR2643817B1
(fr)
|
1989-03-06 |
1993-12-17 |
Transgene Sa |
Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
|
|
DE3642912A1
(de)
|
1986-12-16 |
1988-06-30 |
Leybold Ag |
Messeinrichtung fuer paramagnetische messgeraete mit einer messkammer
|
|
US6222020B1
(en)
|
1987-01-07 |
2001-04-24 |
Imperial Cancer Research Technology Limited |
Antigens derived from the core protein of the human mammary epithelial mucin
|
|
FR2632863B2
(fr)
|
1987-10-29 |
1990-08-31 |
Transgene Sa |
Virus du fowlpox recombinant et vaccins derives de ces virus
|
|
US5100587A
(en)
|
1989-11-13 |
1992-03-31 |
The United States Of America As Represented By The Department Of Energy |
Solid-state radioluminescent zeolite-containing composition and light sources
|
|
FR2668064B1
(fr)
|
1990-10-23 |
1994-12-16 |
Transgene Sa |
Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.
|
|
US5756102A
(en)
|
1990-11-20 |
1998-05-26 |
Virogenetics Corporation |
Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
EP0575491B1
(en)
|
1991-03-07 |
2003-08-13 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
US5179993A
(en)
|
1991-03-26 |
1993-01-19 |
Hughes Aircraft Company |
Method of fabricating anisometric metal needles and birefringent suspension thereof in dielectric fluid
|
|
US6013638A
(en)
|
1991-10-02 |
2000-01-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
|
|
US6133028A
(en)
|
1993-05-28 |
2000-10-17 |
Transgene S.A. |
Defective adenoviruses and corresponding complementation lines
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
US5698443A
(en)
|
1995-06-27 |
1997-12-16 |
Calydon, Inc. |
Tissue specific viral vectors
|
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
AU713040B2
(en)
|
1994-07-15 |
1999-11-18 |
University Of Iowa Research Foundation, The |
Immunomodulatory oligonucleotides
|
|
US6638762B1
(en)
|
1994-11-28 |
2003-10-28 |
Genetic Therapy, Inc. |
Tissue-vectors specific replication and gene expression
|
|
US5998205A
(en)
|
1994-11-28 |
1999-12-07 |
Genetic Therapy, Inc. |
Vectors for tissue-specific replication
|
|
FR2727689A1
(fr)
|
1994-12-01 |
1996-06-07 |
Transgene Sa |
Nouveau procede de preparation d'un vecteur viral
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
DE69633565T3
(de)
|
1995-06-15 |
2013-01-17 |
Crucell Holland B.V. |
Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
|
|
EP0954593A1
(en)
|
1996-07-25 |
1999-11-10 |
Therion Biologics Corporation |
Recombinant pox virus for immunization against tumor-associated antigens
|
|
FR2751879B1
(fr)
|
1996-07-30 |
1998-10-30 |
Transgene Sa |
Composition pharmaceutique contre les tumeurs et infections a papillomavirus
|
|
AU6004798A
(en)
*
|
1997-02-06 |
1998-08-26 |
University College Dublin |
Electrochromic system
|
|
CA2282300C
(en)
|
1997-02-24 |
2011-08-02 |
Therion Biologics Corporation |
Recombinant pox virus for immunization against muc1 tumor-associated antigen
|
|
WO1998039017A1
(en)
*
|
1997-03-07 |
1998-09-11 |
Akira Hayashi |
Immunotherapeutic agent for cancer containing nucleoidal component of bacterium as active ingredient
|
|
JPH10306029A
(ja)
*
|
1997-03-07 |
1998-11-17 |
Akira Hayashi |
細菌の菌体成分を有効成分とする癌免疫療法剤
|
|
US20030138454A1
(en)
*
|
1997-06-09 |
2003-07-24 |
Oxxon Pharmaccines, Ltd. |
Vaccination method
|
|
FR2766091A1
(fr)
|
1997-07-18 |
1999-01-22 |
Transgene Sa |
Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee
|
|
WO2000046355A2
(en)
|
1999-02-04 |
2000-08-10 |
Geron Corporation |
Telomerase reverse transcriptase transcriptional regulatory sequences
|
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
|
GB9819726D0
(en)
|
1998-09-11 |
1998-11-04 |
Advanced Environmental Enginee |
Vapour recovery system
|
|
US20020037274A1
(en)
|
1998-10-26 |
2002-03-28 |
Angelica Williams |
Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
|
|
FR2787465A1
(fr)
|
1998-12-21 |
2000-06-23 |
Transgene Sa |
Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
|
|
CA2364934C
(fr)
|
1999-02-22 |
2011-10-18 |
Transgene S.A. |
Procede d'obtention d'une preparation virale purifiee
|
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
WO2001036650A2
(en)
|
1999-11-15 |
2001-05-25 |
Onyx Pharmaceuticals, Inc. |
An oncolytic adenovirus
|
|
AUPQ520800A0
(en)
|
2000-01-21 |
2000-02-17 |
Alfred Hospital |
Prime-boost vaccination strategy
|
|
HU230198B1
(hu)
|
2000-11-23 |
2015-10-28 |
Bavarian Nordic A/S |
Módosított Vacciniavírus Ankara-variáns
|
|
ES2424131T3
(es)
*
|
2001-03-27 |
2013-09-27 |
Oncothyreon Inc. |
Vacuna para modular respuestas inmunitarias entre T1 y T2
|
|
GB0118532D0
(en)
|
2001-07-30 |
2001-09-19 |
Isis Innovation |
Materials and methods relating to improved vaccination strategies
|
|
AT500647A1
(de)
*
|
2002-05-21 |
2006-02-15 |
Igeneon Krebs Immuntherapie |
Verwendung eines impfstoffes
|
|
AU2003241252A1
(en)
*
|
2002-06-06 |
2003-12-22 |
Immunicum Ab |
New method and composition for producing a cellular allogeneic vaccine
|
|
NZ540098A
(en)
|
2002-10-29 |
2008-09-26 |
Coley Pharmaceutical Group Ltd |
Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
|
|
US20040197304A1
(en)
*
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
|
FR2855758B1
(fr)
|
2003-06-05 |
2005-07-22 |
Biomerieux Sa |
Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique
|
|
WO2005035779A2
(en)
*
|
2003-10-10 |
2005-04-21 |
Powderject Vaccines, Inc |
Method
|
|
FR2862648B1
(fr)
|
2003-11-21 |
2006-02-03 |
Biomerieux Sa |
Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l 'hepatite c
|
|
EP1712243A4
(en)
*
|
2004-01-13 |
2007-04-11 |
Dnavec Research Inc |
GENE THERAPY FOR TUMOR USING A NEGATIVE CHAIN RNA VIRAL VECTOR ENCODING AN IMMUNOSTIMULATORY CYTOKINE
|
|
WO2005118884A1
(en)
*
|
2004-05-28 |
2005-12-15 |
The United States Of America As Represented By The Secretary Of The Navy |
A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
|
|
CN101035901A
(zh)
*
|
2004-07-22 |
2007-09-12 |
细胞基因系统有限公司 |
腺病毒载体中转基因的插入
|
|
JP5024830B2
(ja)
*
|
2004-10-25 |
2012-09-12 |
ステーテンズ セーラム インスティテュート |
クラミジア・トラコマチス（Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓ）抗原のワクチンおよび診断への使用
|
|
CN101355928B
(zh)
*
|
2005-04-26 |
2013-05-22 |
卫材R&D管理株式会社 |
用于癌症免疫疗法的组合物和方法
|
|
PT2366400E
(pt)
*
|
2005-06-28 |
2016-02-02 |
Oncothyreon Inc |
Método de tratamento de doentes com uma vacina à base de glicoproteína mucinosa (muc-1)
|
|
US20090305258A1
(en)
*
|
2006-02-17 |
2009-12-10 |
Paolo La Colla |
Methods for the diagnosis of proliferative and/or conformational diseases
|
|
EP2199793A4
(en)
*
|
2007-09-10 |
2012-01-11 |
Riken |
METHOD FOR EVALUATING HUMAN DENDRITIC CELLS AND HUMAN-CELL IMMUNOTHERAPEUTICS
|